Table 1 Study characteristics
Study characteristics | ||||
|---|---|---|---|---|
S.No | Study | Region | Type of study | Source of funding |
1 | Quinn et al., 2005 | Europe (United Kingdom) | Randomized controlled trial | Not disclosed |
2 | Nawata et al., 2008 | Asia (Japan) | Observational/prospective | Government |
3 | Brocq et al., 2009 | Europe (France) | Observational/prospective | Not disclosed |
4 | Tanaka et al., 2010 | Asia (Japan) | Observational/prospective | Government |
5 | van den Broek et al., 2011 | Europe (Netherland) | Randomized, multicenter, single blind | Not disclosed |
6 | van der Maas et al., 2012 | Europe (Netherland) | Observational/prospective | Not disclosed |
7 | Harigai et al., 2012 | Asia (Japan) | Observational/retrospective | Government |
8 | Hirata et al., 2013 | Asia (Japan) | Observational/prospective | Government |
9 | Smolen et al., 2013 | Europe, Latin America, Asia, Australia | Randomized controlled trial | Industry |
10 | Iwamoto et al., 2014 | Asia (Japan) | Observational/prospective | Not disclosed |
11 | Kádár et al., 2014 | Europe (Hungary) | Retrospective, multicenter, cohort | Government |
12 | Tanaka et al., 2015 | Europe (Hungary) | Observational/prospective | Government |
13 | Moghadam et al., 2016 | Europe (Netherland) | Randomized controlled trial, multicenter, open label | Government |
14 | NCT00808509 (ADMIRE) | Europe (Sweden) | Randomized, parallel group, open label | Industry |
15 | NCT00858780 (DOSERA) | Europe (Denmark, Finland, Hungary, Iceland, Norway, Sweden) | Randomized controlled trial, double blind | Industry |
16 | NCT00858780 (DOSERA) b | Europe (Denmark, Finland) | Randomized controlled trial, double blind | Industry |